Parapneumonic effusions and empyema

Proceedings of the American Thoracic Society

Volumn 3, Issue 1, 2006, Pages 75-80

  Light, Richard W ^a,b  

^a VANDERBILT UNIVERSITY   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Decortication; Fibrinolytics; Pleural effusion; Thoracoscopy

Indexed keywords

DEOXYRIBONUCLEASE; DORNASE ALFA; FIBRINOLYTIC AGENT; RECOMBINANT DEOXYRIBONUCLEASE; STREPTODORNASE; STREPTODORNASE PLUS STREPTOKINASE; STREPTOKINASE; TISSUE PLASMINOGEN ACTIVATOR; UNCLASSIFIED DRUG; UROKINASE;

CLINICAL TRIAL; DECORTICATION; DRUG COST; EMPYEMA; FEVER; FIBRINOLYTIC THERAPY; HOSPITALIZATION; HUMAN; LEUKOCYTOSIS; LUNG FUNCTION; LYSIS; MALAISE; MORTALITY; NONHUMAN; OUTCOME ASSESSMENT; PLEURA EFFUSION; PLEURA FLUID; PNEUMONIA; PROGNOSIS; RADIOGRAPHY; REVIEW; RISK ASSESSMENT; STATISTICAL SIGNIFICANCE; SURGICAL DRAINAGE; THORACOCENTESIS; THORACOTOMY;

EMPYEMA, PLEURAL; HUMANS; PLEURAL EFFUSION; PNEUMONIA; PROGNOSIS; SURVIVAL RATE; THORACIC SURGERY, VIDEO-ASSISTED;

EID: 33644501812     PISSN: 15463222     EISSN: None     Source Type: Journal    
DOI: 10.1513/pats.200510-113JH     Document Type: Review

References (51)

1. Light RW. Pleural diseases, 4th ed. Baltimore: Lippincott, Williams and Wilkins; 2001.
2. Andrews NC, Parker EF, Shaw RR, Wilson NJ,Webb WR. Management of nontuberculous empyema. Am Rev Respir Dis 1962;85:935-936.
3. Hasley PB, Albaum MN, Li Y-H, Fuhrman CR, Britton CA, Marrie TJ, Singer DE, Coley CM, Kapoor WN, Fine MJI. Do pulmonary radiographic findings at presentation predict mortality in patients with community-acquired pneumonia? Arch Intern Med 1996;156:2206-2212.
4. Fine MJ, Auble TE, Yealy DM, Hanusa BH, Weissfold LA, Singer DE, Coley CM, Marrie TJ, Kapoor WN. A prediction rule to identify low-risk patients with community-acquired pneumonia. JAMA 1996;275:134-141.
5. Bartlett JG, Finegold SM. Anaerobic infections of the lung and pleural space. Am Rev Respir Dis 1974;110:56-77.
6. Light RW, Girard WM, Jenkinson SG, George RB. Parapneumonic effusions. Am J Med 1980;69:507-511.
7. 2. Chest 1973;64:591-596.
8. Cheng D-S, Rodriguez RM, Rogers J, Wagster M, Starnes DL, Light RW. Comparison of pleural fluid pH values obtained using blood gas machine, pH meter, and pH indicator strip. Chest 1998;114:1368-1372.
9. Colice GL, Curtis A, Deslauriers J, Heffner J, Light RW, Littenberg B, Sahn S, Weinstein RA, Yusen RD. Medical and surgical treatment of parapneumonic effusions: an evidence-based guideline. Chest 2000;118:1158-1171.
10. Cham CW, Haq SM, Rahamim J. Empyema thoracis: a problem with late referral? Thorax 1993;48:925-927.
11. Bowditch HI. Paracentesis thoracic: an analysis of 25 cases of pleuritic effusion. Am Med Monthly 1853;3-45.
12. Snider GL, Saleh SS. Empyema of the thorax in adults: review of 105 cases. Chest 1968;54:12-17.
13. Sasse S, Nguyen T, Teixeira LR, Light RW. The utility of daily therapeutic thoracentesis for the treatment of early empyema. Chest 1999;116:1703-1708.
14. Storm HKR, Krasnik M, Bang K, Frimodt-Moller N. Treatment of pleural empyema secondary to pneumonia: thoracocentesis regimen versus tube drainage. Thorax 1992;47:821-824.
15. Simmers TA, Jie C, Sie B. Minimally invasive treatment of thoracic empyema. Thorac Cardiovasc Surg 1999;47:77-81.
16. Shankar S, Gulati M, Kang M, Gupta S, Suri S. Image-guided percutaneous drainage of thoracic empyema: can sonography predict the outcome? Eur Radiol 2000;10:495-499.
17. Ali I, Unruh H. Management of empyema thoracis. Ann Thorac Surg 1990;50:355-359.
18. Ashbaugh DG. Empyema thoracis: factors influencing morbidity and mortality. Chest 1991;99:1162-1165.
19. Tillett WS, Sherry S, Read CT. The use of streptokinase-streptodornase in the treatment of postpneumonic empyema. J Thorac Surg 1951;21:275-297.
20. Light RW, Nguyen T, Mulligan ME, Sasse SA. The in vitro efficacy of varidase versus streptokinase or urokinase for liquefying thick purulent exudative material from loculated empyema. Lung 2000;178:13-18.
21. Bergh NP, Ekroth R, Larsson S, Nagy P. Intrapleural streptokinase in the treatment of haemothorax and empyema. Scand J Thorac Cardiovasc Surg 1977;11:265-268.
22. Bouros D, Schiza S, Patsourakis G, Chalkiadakis G, Panagou P, Siafakas NM. Intrapleural streptokinase versus urokinase in the treatment of complicated parapneumonic effusions: a prospective, double-blind study. Am J Respir Crit Care Med 1997;155:291-295.
23. Jerjes-Sanchez C, Ramirez-Rivera A, Elizalde JJ, Delgado R, Cicero R, Ibarra-Perez C, Arroliga AC, Padua A, Portales A, Villarreal A, et al. Intrapleural fibrinolysis with streptokinase as an adjunctive treatment in hemothorax and empyema: amulticenter trial. Chest 1996;109:1514-1519.
24. Laisaar T, Puttsepp E, Laisaar V. Early administration of intrapleural streptokinase in the treatment of multiloculated pleural effusions and pleural empyemas. Thorac Cardiovasc Surg 1996;44:252-256.
25. Temes RT, Follis F, Kessler RM, Pett SB Jr, Wernly JA. Intrapleural fibrinolytics in management of empyema thoracis. Chest 1996;110:102-106.
26. Moulton JS, Moore PT, Mencini RA. Treatment of loculated pleural effusions with transcatheter intracavitary urokinase. AJR Am J Roentgenol 1989;153:941-945.
27. Bishop NB, Pon S, Ushay HM, Greenwald BM. Alteplase in the treatment of complicated parapneumonic effusion: a case report. Pediatrics 2003;111:E188-E190.
28. Skeete DA, Rutherford EJ, Schlidt SA, Abrams JE, Parker LA, Rich PB. Intrapleural tissue plasminogen activator for complicated pleural effusions. J Trauma 2004;57:1178-1183.
29. Weinstein M, Restrepo R, Chait PG, Connolly B, Temple M, Macarthur C. Effectiveness and safety of tissue plasminogen activator in the management of complicated parapneumonic effusions. Pediatrics 2004;113:e182-e185.
30. Ray TL, Berkenbosch JW, Russo P, Tobias JD. Tissue plasminogen activator as an adjuvant therapy for pleural empyema in pediatric patients. J Intensive Care Med 2004;19:44-50.
31. Chin NK, Lim TK. Controlled trial of intrapleural streptokinase in the treatment of pleural empyema and complicated parapneumonic effusions. Chest 1997;111:275-279.
32. Davies RJO, Traill ZC, Gleeson FV. Randomised controlled trial of intrapleural streptokinase in community acquired pleural infection. Thorax 1997;52:416-421.
33. Bouros D, Schiza S, Tzanakis N, Chalkiadakis G, Drositis J, Siafakas N. Intrapleural urokinase versus normal saline in the treatment of complicated parapneumonic effusions and empyema: a randomized, doubleblind study. Am J Respir Crit Care Med 1999;159:37-42.
34. Tuncozgur B, Ustunsoy H, Sivrikoz MC, Dikensoy O, Topal M, Sanli M, Elbeyli L. Intrapleural urokinase in the management of parapneumonic empyema: a randomised controlled trial. Int J Clin Pract 2001;55:658-660.
35. Diacon AH, Theron J, Schuurmans MM, Van De Wal BW, Bolliger CT. Intrapleural streptokinase for empyema and complicated parapneumonic effusions. Am J Respir Crit Care Med 2004;170:49-53.
36. Maskell NA, Davies CW, Nunn AJ, Hedley EL, Gleeson FV, Miller R, Gabe R, Rees GL, Peto TE, Woodhead MA, et al.; First Multicenter Intrapleural Sepsis Trial (MIST1) Group. U.K. controlled trial of intrapleural streptokinase for pleural infection. N Engl J Med 2005;352:865-874.
37. Simpson G, Roomes D, Heron M. Effects of streptokinase and deoxyribonuclease on viscosity of human surgical and empyema pus. Chest 2000;117:1728-1733.
38. Silen ML, Naunheim KS. Thoracoscopic approach to the management of empyema thoracis: indications and results. Chest Surg Clin N Am 1996;6:491-499.
39. Landreneau RJ, Keenan RJ, Hazelrigg SR, Mack MJ, Naunhein KS. Thoracoscopy for empyema and hemothorax. Chest 1995;109:18-24.
40. Cassina PC, Hauser M, Hillejan L, Greschuchna D, Stamatis G. Video-assisted thoracoscopy in the treatment of pleural empyema: stagebased management and outcome. J Thorac Cardiovasc Surg 1999;117:234-238.
41. Lawrence DR, Ohri SK,Moxon RE, Townsend ER, Fountain SW. Thoracoscopic debridement of empyema thoracis. Ann Thorac Surg 1997;64:1448-1450.
42. Striffeler H, Gugger M, Im Hof V, Cerny A, Furrer M, Ris HB. Videoassisted thoracoscopic surgery for fibrinopurulent pleural empyema in 67 patients. Ann Thorac Surg 1998;65:319-323.
43. Wait MA, Sharma S, Hohn J, Dal Nogare A. A randomized trial of empyema therapy. Chest 1997;111:1548-1551.
44. Thurer RJ. Decortication in thoracic empyema: indications and surgical technique. Chest Surg Clin N Am 1996;6:461-490.
45. Pothula V, Krellenstein DJ. Early aggressive surgical management of parapneumonic empyemas. Chest 1994;105:832-836.
46. Angelillo Mackinlay TA, Lyons GA, Chimondeguy DJ, Piedras MA, Angaramo G, Emery J. VATS debridement versus thoracotomy in the treatment of loculated postpneumonia empyema. Ann Thorac Surg 1996;61:1626-1630.
47. Neff CC, van Sonnenberg E, Lawson DW, Patton AS. CT follow-up of empyemas: pleural peels resolve after percutaneous catheter drainage. Radiology 1990;176:195-197.
48. Rzyman W, Skokowski J, Romanowicz G, Lass P, Dziadziuszko R. Decortication in chronic pleural empyema: effect on lung function. Eur J Cardiothorac Surg 2002;21:502-507.
49. Deslauriers J, Jacques LF, Gregoire J. Role of Eloesser flap and thoracoplasty in the third millennium. Chest Surg Clin N Am 2002;12:605-623.
50. Empyema Commission. Cases of empyema at Camp Lee, Virginia. JAMA 1918;71:366-373.
51. Waller DA, Rengarajan A. Thoracoscopic decortication: a role for videoassisted surgery in chronic postpneumonic pleural empyema. Ann Thorac Surg 2001;71:1813-1816.